Curcumin stimulates glucose uptake through AMPK-p38 MAPK pathways in L6 myotube cells

Journal of Cellular Physiology

Volumn 223, Issue 3, 2010, Pages 771-778

  Kim, Ji Hae ^a   Park, Ji Man ^b   Kim, Eung Kyun ^b   Lee, Jung Ok ^a   Lee, Soo Kyung ^a   Jung, Jin Hee ^a   You, Ga Young ^a   Park, Sun Hwa ^a   Shu, Pann Ghill ^b   Kim, Hyeon Soo ^a  

^a Korea University College of Medicine   (South Korea)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; CURCUMIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE P38; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; GLUCOSE TRANSPORT; MALE; METABOLIC REGULATION; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SKELETAL MUSCLE; ANIMAL; C57BL MOUSE; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; MOUSE; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

MUS; RATTUS;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL LINE; CURCUMIN; GLUCOSE; INJECTIONS, INTRAPERITONEAL; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RATS;

EID: 77951244999     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22093     Document Type: Article

References (39)

1. Ammon HP, Anazodo MI, Safayhi H, Dhawan BN, Srimal RC. 1992. Curcumin: A potent inhibitor of leukotriene B4 formation in rat peritoneal polymorphonuclear neutrophils (PMNL). Planta Med 58:226.
2. Antonescu CN, Huang C, Niu W, Liu Z, Eyers PA, Heidenreich KA, Bilan PJ, Klip A. 2005. Reduction of insulin-stimulated glucose uptake in L6 myotubes by the protein kinase inhibitor SB203580 is independent of p38 MAPK activity. Endocrinology 146:3773-3781. (Pubitemid 41175745)
3. Bazuine M, Ouwens DM, Gomes de Mesquita DS, Maassen JA. 2003. Arsenite stimulated glucose transport in 3T3-L1 adipocytes involves both Glut4 translocation and p38 MAPK activity. Eur J Biochem 270:3891-3903.
4. Conrad PW, Rust RT, Han J, Milhorn DE, Beitner-Johnson D. 1999. Selective activation of p38 alpha and p38 gamma by hypoxia. Role in regulation of cyclin D1 by hypoxia in PC12 cells. J Biol Chem 274:23570-23576. (Pubitemid 129529198)
5. Crute BE, Seefeld K, Gamble J, Kemp BE, Witters LA. 1998. Functional domains of the alpha1 catalytic subunit of the AMP-activated protein kinase. J Biol Chem 273:35347-35354. (Pubitemid 29028244)
6. Fryer LG, Parbu-Patel A, Carling D. 2002. The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem 277:25226-25232. (Pubitemid 34951829)
7. Godl K, Wissing J, Kurtenbach A, Habenberger P, Blencke S, Gutbroad H, Salassidis K, Stein-Gerlach M, Missio A, Cotton M, Daub H. 2003. An efficient proteomics method to identify the cellular targets of protein kinase inhibitors. Proc Natl Acad Sci USA 100:15434-15439.
8. Govindarajan VS. 1980. Turmeric - Chemistry, technology, and quality. Crit Rev Food Sci Nutr 12:199-301.
9. Green S, Wahli W. 1994. Peroxisome proliferator-activated receptors: Finding the orphan a home. Mol Cell Endocrinol 100:149-153.
10. Hardie DG. 2004. The AMP-activated protein kinase pathway - New players upstream and downstream. J Cell Sci 117:5479-5487.
11. Hardie DG, Carling D, Carlson M. 1998. The AMP-activated/SNF1 protein kinase subfamily: Metabolic sensors of the eukaryotic cell? Annu Rev Biochem 67:821-855.
12. Hardie DG, Scott JW, Pan DA, Hudson ER. 2003. Management of cellular energy by the AMPactivated protein kinase system. FEBS Lett 546:113-120.
13. Hawley SA, Gadalla AE, Olsen GS, Hardie DG. 2002. The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes 51:2420-2425.
14. Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, Makela TP, Alessi DR, Hardie DG. 2003. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2:28.
15. Hayashi T, Hirshman MF, Fujii N, Habinowski SA, Witters LA, Goodyear LJ. 2000. Metabolic stress and altered glucose transport: Activation of AMP-activated protein kinase as a unifying coupling mechanism. Diabetes 49:527-531.
16. Hong SP, Momcilovic M, Carlson M. 2005. Function of mammalian LKB1 and Ca2+/ calmodulin-dependent protein kinase kinase alpha as Snf1-activating kinases in yeast. J Biol Chem 280:21804-21809.
17. Huang MT, Smart RC, Wong CQ, Conney AH. 1988. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 48:5941-5946.
18. Huang HC, Jan TR, Yeh SF. 1992. Inhibitory effect of curcumin, an anti-inflammatory agent, on vascular smooth muscle cell proliferation. Eur J Pharmacol 221:381-384.
19. Hurley RL, Anderson KA, Franzone JM, Kemp BE, Means AR, Witters LA. 2005. The Ca2+/ calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem 280:29060-29066.
20. Jakobsen SN, Hardie DG, Morrice N, Tornqvist HE. 2001. 5′-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside. J Biol Chem 276:46912-46916.
21. Kahn BB, Alquier T, Carling D, Hardie DG. 2005. AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1:15-25.
22. Kim MS, Park JY, Namkoong C, Jang PG, Ryu JW, Song HS, Yun JY, Namgoong IS,Ha J, Park IS, Lee IK, Viollet B, Youn JH, Lee HK, Lee KU. 2004. Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase.Nat Med 10:727-733.
23. Kim T, Davis J, Zhang AJ, He X, Mathews ST. 2009. Curcumin activates AMPK and suppresses gluconeogenic gene expression in hepatoma cells. Biochem Biophys Res Commun 388:377-382.
24. Kuroda M, Mimaki Y, Nishiyama T, Mae T, Kishida H, Tsukagawa M, Takahashi K, Kawada T, Nakagawa K, Kitahara M. 2005. Hypoglycemic effects of turmeric (Curcuma longa L. rhizomes) on genetically diabetic KK-Ay mice. Biol Pharm Bull 28:937-939.
25. Lee YM, Lee JO, Jung JH, Kim JH, Park SH, Park JM, Kim EK, Suh PG, Kim HS. 2008. Retinoic acid leads to cytoskeletal rearrangement through AMPK-Rac1 and stimulates glucose uptake through AMPK-p38 MAPK in skeletal muscle cells. J Biol Chem 283:33969-33974.
26. Lemieux K, Konrad D, Klip A, Marette A. 2003. The AMP-activated protein kinase activator AICAR does not induce GLUT4 translocation to transverse tubules but stimulates glucose uptake and p38 mitogen-activated protein kinases alpha and beta in skeletal muscle. FASEB J 17:1658-1665.
27. Mazumder A, Raghavan K, Weinstein J, Kohn KW, Pommier Y. 1995. Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochem Pharmacol 49:1165-1170.
28. Musi N, Goodyear LJ. 2003. AMP-activated protein kinase and muscle glucose uptake. Acta Physiol Scand 178:337-345.
29. Okuno A, Tamemoto H, Tobe K, Ueki K, Mori Y, Iwamoto K, Umesono K, Akanuma Y, Fujiwara T, Horikoshi H, Yazaki Y, Kadowaki T. 1998. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest 101:1354-1361.
30. Pelletier A, Joly E, Prentki M, Coderre L. 2005. Adenosine 50-monophosphate-activated protein kinase and p38 mitogen-activated protein kinase participate in the stimulation of glucose uptake by dinitrophenol in adult cardiomyocytes. Endocrinology 146:2285-2294.
31. Reddy AC, Lokesh BR. 1992. Studies on spice principles as antioxidants in the inhibition of lipid peroxidation of rat liver microsomes. Mol Cell Biochem 111:117-124.
32. Reddy AC, Lokesh BR. 1994. Effect of dietary turmeric (Curcuma longa) on iron-induced lipid peroxidation in the rat liver. Food Chem Toxicol 32:279-283.
33. Ryder JW, Fahlman R, Wallberg-Henriksson H, Alessi DR, Krook A, Zierath JR. 2000. Effect of contraction on mitogen-activated protein kinase signal transduction in skeletal muscle. Involvement of the mitogen- and stress-activated protein kinase 1. J Biol Chem 275:1457-1462.
34. Somwar R, Perreault M, Kapur S, Taha C, Sweeney G, Ramlal T, Kim DY, Keen J, Cote CH, Klip A, Marette A. 2000. Activation of p38 mitogen-activated protein kinase alpha and beta by insulin and contraction in rat skeletal muscle: Potential role in the stimulation of glucose transport. Diabetes 49:1794-1800.
35. Somwar R, Koterski S, Sweeney G, Sciotti R, Djuric S, Berg C, Trevillyan J, Scherer PE, Rondinone CM, Klip A. 2002. A dominant-negative p38 MAPK mutant and novel selective inhibitors of p38 MAPK reduce insulin-stimulated glucose uptake in 3T3-L1 adipocytes without affecting GLUT4 translocation. J Biol Chem 277:50386-50395.
36. Srimal RC, Dhawan BN. 1973. Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol 25:447-452.
37. Stein SC, Woods A, Jones NA, Davison MD, Carling D. 2000. The regulation of AMP-activated protein kinase by phosphorylation. Biochem J 345:437-443.
38. Woods A, Johnstone SR, Dickerson K, Leiper FC, Fryer LG, Neumann D, Schlattner U, Wallimann T, Carlson M, Carling D. 2003. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 13:2004-2008. (Pubitemid 37425212)
39. Xi X, Han J, Zhang JZ. 2001. Stimulation of glucose transport by AMP-activated protein kinase via activation of p38 mitogen-activated protein kinase. J Biol Chem 276:41029-41034. (Pubitemid 37373255)